PL2956136T3 - D-fagomina do zapobiegania wystąpienia chorób autoimmunologicznych - Google Patents

D-fagomina do zapobiegania wystąpienia chorób autoimmunologicznych

Info

Publication number
PL2956136T3
PL2956136T3 PL14704342T PL14704342T PL2956136T3 PL 2956136 T3 PL2956136 T3 PL 2956136T3 PL 14704342 T PL14704342 T PL 14704342T PL 14704342 T PL14704342 T PL 14704342T PL 2956136 T3 PL2956136 T3 PL 2956136T3
Authority
PL
Poland
Prior art keywords
fagomine
onset
preventing
autoimmune diseases
autoimmune
Prior art date
Application number
PL14704342T
Other languages
English (en)
Inventor
Sergio Pumarola Segura
Maria Carmen Antolin Maté
Marta LLOPIS PAGÉS
Maria De Los Angeles Calvo Torras
Original Assignee
Sergio Pumarola Segura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sergio Pumarola Segura filed Critical Sergio Pumarola Segura
Publication of PL2956136T3 publication Critical patent/PL2956136T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PL14704342T 2013-02-18 2014-02-13 D-fagomina do zapobiegania wystąpienia chorób autoimmunologicznych PL2956136T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13155586.4A EP2767284A1 (en) 2013-02-18 2013-02-18 D-Fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response
EP14704342.6A EP2956136B1 (en) 2013-02-18 2014-02-13 D-fagomine for preventing the onset of autoimmune diseases
PCT/EP2014/052802 WO2014125013A1 (en) 2013-02-18 2014-02-13 D-fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response

Publications (1)

Publication Number Publication Date
PL2956136T3 true PL2956136T3 (pl) 2019-06-28

Family

ID=47739125

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14704342T PL2956136T3 (pl) 2013-02-18 2014-02-13 D-fagomina do zapobiegania wystąpienia chorób autoimmunologicznych

Country Status (12)

Country Link
US (1) US10233206B2 (pl)
EP (2) EP2767284A1 (pl)
CN (1) CN105246479B (pl)
DK (1) DK2956136T3 (pl)
EA (1) EA030688B1 (pl)
ES (1) ES2711136T3 (pl)
LT (1) LT2956136T (pl)
MX (1) MX362363B (pl)
PL (1) PL2956136T3 (pl)
PT (1) PT2956136T (pl)
UA (1) UA119746C2 (pl)
WO (1) WO2014125013A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6806947B1 (ja) * 2019-12-27 2021-01-06 サントリーホールディングス株式会社 オフフレーバーが低減された緑茶飲料
JP6808082B1 (ja) * 2019-12-27 2021-01-06 サントリーホールディングス株式会社 苦味が強化された緑茶飲料
CN112385539A (zh) * 2020-11-05 2021-02-23 贵州师范大学 一种果壳不破裂早熟优质黑米荞的选育方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006223285A (ja) * 2005-02-16 2006-08-31 Manjiro Kuwashige そば湯飲料とその加工方法
CN1321588C (zh) * 2005-03-22 2007-06-20 上海应用技术学院 荞麦谷果蔬泡腾片的制备方法
CN101129476B (zh) * 2006-08-21 2013-07-24 中国医学科学院药物研究所 桑枝生物碱有效部位在制备降血糖药物中的应用
CN101606936B (zh) * 2008-06-20 2011-12-28 中南大学 一种治疗糖尿病的药物组合物
WO2010029313A1 (en) * 2008-09-11 2010-03-18 Summit Corporation Plc. Antiinfective compounds
CN101810276A (zh) * 2009-10-19 2010-08-25 郑鉴忠 荞麦萌芽活性食品生产方法
PL2549994T3 (pl) 2010-03-25 2016-06-30 Taihua Shouyue Hong Kong International Co Ltd Zastosowanie D-fagominy jako inhibitora przylegania bakterii do komórek nabłonka
EP2593557A1 (en) 2010-07-16 2013-05-22 Bioglane, S.L.N.E. A buckwheat extract enriched in d-fagomine

Also Published As

Publication number Publication date
DK2956136T3 (en) 2019-03-18
EA030688B1 (ru) 2018-09-28
LT2956136T (lt) 2019-03-12
PT2956136T (pt) 2019-02-19
US20150368283A1 (en) 2015-12-24
US10233206B2 (en) 2019-03-19
MX2015010631A (es) 2016-05-26
MX362363B (es) 2019-01-11
CN105246479A (zh) 2016-01-13
EA201591518A1 (ru) 2016-01-29
WO2014125013A1 (en) 2014-08-21
UA119746C2 (uk) 2019-08-12
EP2956136A1 (en) 2015-12-23
EP2956136B1 (en) 2018-11-21
CN105246479B (zh) 2019-03-15
EP2767284A1 (en) 2014-08-20
ES2711136T3 (es) 2019-04-30

Similar Documents

Publication Publication Date Title
IL241101A0 (en) Medicinal uses of empagliflozin
HUE060721T2 (hu) Empagliflozin terápiás alkalmazásai
IL241102B (en) Medicinal uses of empagliflozin
PL2981271T3 (pl) Zastosowania terapeutyczne empagliflozyny
PT3071247T (pt) Dispositivo para a construção de pele
GB201308440D0 (en) Therapeutic
ZA201506965B (en) Bicyclic compounds
GB201312155D0 (en) Therapeutic invention
ZA201507718B (en) The local treatment of inflammatory ophthalmic diseases
SG11201505692QA (en) Reducing the risk of autoimmune disease
GB201318668D0 (en) Sonosensitive therapeutic
GB201313356D0 (en) Therapeutic Intervention
LT2956136T (lt) D-fagominas, skirtas autoimuninių ligų pradžios prevencijai
PT2948129T (pt) Compostos terapêuticos
GB201314286D0 (en) Therapeutic Compounds
GB201312499D0 (en) Therapeutic compounds
PL3065678T3 (pl) Pessarium terapeutyczne
GB201320905D0 (en) Therapeutic compounds
GB201309967D0 (en) Therapeutic combinations
TWM475821U (en) Structure of mosquito-catch
GB201308840D0 (en) Insole
IL241242A0 (en) Artificial peptides for the treatment of autoimmune diseases
AU351522S (en) Bowl
PH32013000882S1 (en) Bowl
GB201314397D0 (en) Therapeutic Compounds